At present the Middle East region constitutes as small percent of global pharmaceutical sales. However, ever-increasing populations and governmental healthcare reforms are likely to increase demand. These markets will be essential for pharmaceuticals companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market.

This Kalorama Information report, Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends) takes a thorough look at the emerging markets in these countries:

• Egypt
• United Arab Emirates
• Isreal
• Saudi Arabia
• Jordan

As part of its exhuastive coverage, for each country's market, the report includes:

• Current Pharmaceutical Market Size
• Market Forecast
• Regulatory Environment
• Economic Statistics
• Disease and Health Spending Statistics
• Leading Pharmaceutical Suppliers

In addition, trends that apply to all countries such as generic competition, regulatory matters, Companies profiled in this report include:

• Banaja
• Dar Al Dawa
• GlaxoSmithKline Egypt
• Gulf Pharmaceutical Industries
• Hikma Pharmaceuticals
• Medical Union Pharmaceutical Company
• Perrigo Israel
• Pharco Pharmaceuticals
• Saudi Pharmaceutical Industries & Medical Appliances Corp.
• TEVA

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 30 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2007. Historical data was provided for the years 2005 and 2006, with forecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for each region and/or segment covered. The forecasted market analysis for 2008-2012 was largely based on demographic trends, new developments, and global expansion.

Related Reports:

The World Market for Biosimilars and the Potential for US Follow-on Biologics
Aug 1, 2009 - KLI2402283 - $3,700.00

Rx to OTC Switches 2009
May 1, 2009 - KLI2196300 - $3,500.00

Pharmaceutical Markets in India
Apr 1, 2009 - KLI2155338 - $1,295.00

Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)
Apr 1, 2009 - KLI2123096 - $1,995.00

Pharmaceutical Markets in Russia
Jan 1, 2009 - KLI2074032 - $995.00

Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition
Jan 1, 2009 - KLI1646605 - $3,500.00

Key Healthcare Opportunities for Technology Companies (Wireless in Healthcare 2008-12, High-Tech Patient Monitoring Systems, RFID in Pharma Manufacturing, US EMR Markets, RFID in Healthcare, Electronic Components for Medical Device Markets)
Oct 1, 2008 - KLI1927818 - $7,995.00

The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)
Aug 1, 2008 - KLI1614113 - $2,995.00

Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )
Jul 1, 2008 - KLI1614109 - $2,500.00

Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
May 1, 2008 - KLI1646603 - $3,500.00